Project Grant R01HL173526
Award Date
5/1/24
Completion Date
4/30/29
Dollars Obligated
$1.6M
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
West Hollywood, CA 90048, USA
Similar Awards
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $810,650 to Cedars-Sinai Medical Center to develop and validate an artificial intelligence (AI)-enabled algorithm for automated quantification of fibrotic and calcific aortic valve tissue characteristics from standard computed tomography angiography (CTA). The goal is to predict rapid aortic valve disease progression and...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $791,113 Project Grant (CFDA 93.837 Cardiovascular Diseases Research) to Cedars-Sinai Medical Center. The grant, entitled "Artificial Intelligence Imaging Biomarkers of Longitudinal Cardiovascular Stress," will leverage advanced artificial intelligence (AI) techniques applied to echocardiography imaging data to predict biological cardiovascular age and identify contributors to accelerated versus delayed cardiovascular...
This $834,249 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will fund a comparative study of clinical outcomes, patient experiences, and mechanistic insights between transcatheter and surgical treatment of degenerative mitral regurgitation (DMR). The study, to be conducted by Cedars-Sinai Medical Center, will leverage existing infrastructure to follow approximately 1,800 patients over 10 years,...
This $735,346 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will fund the development of an AI-powered, equitable, interpretable, and generalizable cardiovascular disease (CVD) risk prediction model. The primary awardee is the University of Massachusetts Medical School, which will partner with community health centers and academic hospitals to integrate clinical factors and multi-domain social...
This federal Project Grant award, worth $704,611, was awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The funding supports a research project titled "CAPITALIZING ON ARTIFICIAL INTELLIGENCE TO CAPTURE UNDIAGNOSED STRUCTURAL HEART DISEASE FROM ELECTROCARDIOGRAMS (CACTUS)." The project aims to validate the accuracy of a deep learning model called "ECHONEXT" in detecting undiagnosed structural...
This $656,751 Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) funds the development of an artificial intelligence (AI)-based platform called TCDFLOW by Third Coast Dynamics, Inc. The platform aims to provide 4D hemodynamic assessment of thoracic aortic aneurysms directly from routine clinical anatomic images, without the need for specialized 4D flow MRI techniques and expertise. The two-phase...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) is for the development and validation of a machine learning-based software tool (MCP-ST) to optimize the placement of the MitraClip cardiac device. The $480,989 award to 3DT Holdings, LLC, a minority-owned biomedical engineering company, aims to create software that can predict mitral regurgitation, mean left atrial pressure, mitral valve leaflet...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will develop, validate, and determine the clinical utility of a precision genetic testing approach guided by machine learning algorithms. The $756,895 award to Duke University, with sub-awards to Mayo Clinic and the Medical University of South Carolina, aims to enhance the diagnosis of two monogenic cardiovascular disorders: hypertrophic...
This $753,813 federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) aims to develop personalized prediction models for cardiovascular outcomes using machine learning analysis of cardiac MRI data and genomics. The primary awardee, Yale University, will use convolutional neural networks to identify MRI features that can accurately predict the presence of clonal hematopoiesis of indeterminate potential (CHIP) and predict...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $3,181,696 Project Grant (CFDA 93.837 Cardiovascular Diseases Research) to Vanderbilt University Medical Center (VUMC) to validate an artificial intelligence (AI) technology for accurately measuring skin erythema, a key biomarker of chronic graft-versus-host disease (cGVHD), from patient photographs. The 5-year project will leverage a unique database of over 11,000 photographs and clinical information from diverse cGVHD patients...